SIGLEC15 and neoplasm: By profiling the immune modulators, we found that some suppressors, including B7‐H3, LAG3, VEGFB and Siglec‐15, are significantly upregulated in tumor tissues, which may contribute to the relatively suppressive immune microenvironment in SCCE.